Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02293122
Other study ID # 602-a01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 2014
Est. completion date July 2015

Study information

Verified date August 2023
Source Tomey Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the precision and agreement of the study device, a specular microscope, in comparison to a currently commercially available specular microscope in establishing substantial equivalence of the two devices in clinical use for diagnostic purposes of the human cornea.


Description:

The observational clinical investigation is intended to measure agreement between two diagnostic instruments of the eye's corneal endothelium. The study device is the EM-3000 specular microscope and the control device is the NonCon Robo Pachy (F&A) (CellChek XL) specular microscope. Both instruments measure corneal endothelial cell layer parameters including cell density, coefficient of variation, percent hexagonality, and central thickness. The primary variable is the measurement of agreement between the two instruments for the four parameters described. The secondary variables include repeatability (intra-investigator) and reproducibility both inter-investigator, and inter-instrument. Additionally, measurements of agreement will be made on the EM-3000 using automated analysis with and without touch-up.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Eyes with one of the following corneal conditions: Non-pathologic younger eyes (18-50 yrs) Non-pathologic older eyes (51-80 yrs) Pathologic adult eyes (29-80) Exclusion Criteria 1. Seriously ill or unconscious subject, mentally ill person, mentally handicapped person, person who is unable to read or write. - Non-Pathologic subjects who have the following conditions : 2. History of corneal transplant 3. Long term Fuch's dystrophy (and other corneal endothelial dystrophy) 4. Guttata 5. History of cataract or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device 6. Long term PMMA contact lens use longer than 5 years -Pathologic subjects 7. Keratoconus

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Observational
Intervention is observational to two different diagnostic devices for which comparative readings of the corneal endothelium are being measured; the test device- the EM-3000 Specular Microscope against the Konan Robo-pachy F&A Specular Microscope.

Locations

Country Name City State
United States Ohio State University Columbus Ohio

Sponsors (3)

Lead Sponsor Collaborator
Tomey Corporation Ohio State University, R.P. Chiacchierini & Associates.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Agreement Between EM-3000 and NonCon Robo Pachy F&A (CellChek XL) For Agreement between the two instruments, outcome measures include endothelial cell density (/mm2), coefficient of variation between the two instruments (SD x CD x 10-6, and percent hexagonality of cells in the measured visible field of view between the two instruments. 1 day visit per subject.
Secondary Investigate Repeatability and Reproducibility between the EM-3000 and NonCon Robo Pachy F&A (CellChek XL) Specular Microscopes To investigate repeatability (intra-investigator) in the EM-3000 specular microscope in the four outcome measures of the corneal endothelium as well as corneal thickness.
To investigate reproducibility (inter-investigator/instrument) of the EM-3000 specular microscope in the four outcome measures of the corneal endothelium and corneal thickness.
1 day visit per subject.
See also
  Status Clinical Trial Phase
Terminated NCT03674892 - Intranasal Neurostimulation in Ameliorating Symptoms of Neuropathic Corneal Pain N/A
Recruiting NCT04439552 - fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Not yet recruiting NCT04122651 - Toric Intraocular Lenses for Cataract Patients in the NHS N/A
Recruiting NCT03299530 - Accuracy of Corneal Astigmatism in Different Region Modes
Completed NCT04560790 - Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis N/A
Recruiting NCT03010748 - Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population
Active, not recruiting NCT06389916 - Euclid Phoenix Lens Design Trial N/A
Completed NCT06353776 - MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular Surface N/A
Completed NCT03906513 - Evaluation of the Efficacy of OMK2 in Recovering Corneal Neural Damage in Patients With Diabetes N/A
Not yet recruiting NCT06392607 - Euclid Phoenix Lens Design Trial 2 N/A
Recruiting NCT05232539 - Efficiency of Intraoperative Optical Coherence Tomography (iOCT) N/A
Completed NCT02781948 - Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT N/A
Not yet recruiting NCT05345652 - Evaluation Of Deep Anterior Lamellar Keratoplasty By Anterior Segment Ocular Coherence Tomography
Completed NCT04804592 - Investigation in Corneal Sensation and Contact Lens Wear N/A
Recruiting NCT04626583 - Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells Phase 1
Recruiting NCT04323358 - Agreement and Accuracy of Different Devices for Biometry Measurements in Patients With Cataract N/A
Completed NCT06277349 - Multifocal-toric IOL Compared to Multifocal IOL Combined With Limbal Relaxing Incisions for Correction of Moderate Astigmatism During Cataract Surgery N/A
Withdrawn NCT02395952 - Healing of Persistent Epithelial Defects N/A
Completed NCT03518775 - Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam
Terminated NCT04969406 - A Prospective Trial of the Intelon BOSS(TM) System N/A